BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 8, 2014
View Archived Issues
Clinical study evaluates immunological response EMD-640744 in solid tumors
Read More
Shandong Xuanzhu Pharmaceutical Technology patents novel inhibitors for cancer
Read More
Mitsubishi Tanabe Pharma discloses new TRPM8 agonists for chronic pain
Read More
Meda and Valeant terminate joint ventures in Canada, Mexico and Australia
Read More
Santen and Oak Pharmaceuticals sign U.S. tafluprost licensing agreement
Read More
Pharmacokinetic bioequivalence of biosimilar GP-2017 and reference adalimumab
Read More
Lilly and Deciphera Pharmaceuticals present data on LY-3009120
Read More
Aptiom launched in the U.S. for use as adjunctive treatment of partial-onset seizures
Read More
Novel dendrimer-drug conjugates patented by Indian university
Read More
Mersana Therapeutics and Takeda to develop next-generation antibody-drug conjugates
Read More
IGM-55.5 potently binds and kills B cells in NHL patients
Read More
Soligenix receives SBIR grant award supporting phase II trial of SGX-942
Read More
JNJ-61186372 demonstrates activity for the treatment EGFR/c-Met-aberrant malignancies
Read More
Genentech and Array BioPharma reports ERK-1/2 inhibitor, GDC-0994
Read More
Abbott and AbbVie disclose new PDE10A inhibitors
Read More
Roche and Oryzon to develop epigenetics-based medicines
Read More
Pradaxa approved for deep venous thrombosis and pulmonary embolism
Read More
Merck & Co., Ferring and WHO to study room temperature-stable carbetocin for post-partum hemorrhage
Read More
Daiichi Sankyo extends European PREFER in AF registry
Read More
Cancer Genetics launches CALR mutation analysis test
Read More
Arno Therapeutics enrolls first patient in phase I/II onapristone trial in prostate cancer
Read More
Bristol-Myers Squibb submits daclatasvir and asunaprevir NDAs to FDA for HCV
Read More
Sun Pharmaceutical to acquire Ranbaxy Laboratories from Daiichi Sankyo
Read More
RedHill Biopharma to submit European MAA for RHB-102
Read More
Xenetic Biosciences reports phase I data for PulmoXen in cystic fibrosis
Read More
OncoSec Medical to relaunch phase II CTCL trial of ImmunoPulse DNA IL-12
Read More